Company / Capital Expenditures
SI-BONE, Inc. Capital Expenditures History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$8.4M
FY2025
5-year range
$2.6M / $10.5M
FY2021-FY2025
Trend
-19.8%
vs FY2024
Sector context
#119 of 151
Health Care
What the data says
SI-BONE, Inc.'s capital expenditures of $8M is lower than 79% of companies in the Health Care sector (FY2025). Improved from $8M to $8M over the past 2 years.
Based on SEC 10-K filings.
$8M in FY2025 with a 5-year CAGR of +28.0%.
Improved from $8M to $8M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +9.6%
- 5-Year CAGR
- +28.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 151This company $8.4M Sector average $271.7M
▼
-96.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +28.0%, indicating consistent growth.
- In FY2025, capital expenditures decreased 19.8% year-over-year.
- Ranks #119 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.75 (distress zone, below 1.8 threshold)
- Negative profit margin: -18.5%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.4M | -19.8% |
| FY2024 | $10.5M | +34.6% |
| FY2023 | $7.8M | +22.1% |
| FY2022 | $6.4M | +149.5% |
| FY2021 | $2.6M | +4.7% |
| FY2020 | $2.4M | +159.6% |
| FY2019 | $942.0K | +97.1% |
| FY2018 | $478.0K | +0.0% |
| FY2017 | $478.0K | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 30, 2026